Association Between the (GT)₂₆ Allele in the GRIN2A Promoter and Opioid Use Disorder

• 발행기관: 대한신경정신의학회
• 저자명: Xiaohu Xie Dingding Zhuang Longhui Li Tingting Wu Wenwen Shen Yue Liu Wenjin Xu Qingxiao Hong Zemin Xu Weisheng Chen Jun Gu Wenhua Zhou Huifen Liu
• 간행물 정보: 『Psychiatry Investigation』제22권 제6호, 730~735쪽, 전체 6쪽
• 주제분류: 의약학 > 정신과학
• 파일형태: PDF
• 발행일자: 2025.06.17

국문 초록

Objective N-methyl-D-aspartate (NMDA) receptors are involved in the development of opioid use disorder. The (GT)n polymorphism (rs3219790) in the NMDA receptor 2A subunit gene (GRIN2A) has been proposed as a potential biomarker for risk of opioid use disorder. In this case-control study, we investigated the association between rs3219790 and opioid use disorder in a Chinese Han population. Methods A total of 538 heroin dependent patients and 400 healthy controls were recruited. The genotypes of (GT)n repeats were determined using a polymerase chain reaction-amplifying fragment length polymorphism assay. The association of the (GT)n polymorphism with opioid use disorder and cravings was assessed. Results The frequency of the (GT)26 allele in patients with opioid use disorder was significantly greater than that in the controls (p=0.029, odds ratio=1.264, 95% confidence interval=1.025–1.560), consistent with previous findings. Compared with homozygous carriers of short alleles, carriers of long alleles demonstrated significantly stronger drug cravings (p<0.05). Conclusion The results confirm that the (GT)26 allele of rs3219790 in the GRIN2A promoter is associated with opioid use disorder. Additionally, a longer rs3219790 allele is correlated with stronger drug cravings.

목차

INTRODUCTION

METHODS

RESULTS

DISCUSSION

REFERENCES

키워드

NMDA receptor GRIN2A receptor Gene polymorphism Opioid use disorder